(2021C) HIV/AIDS Update

Recorded On: 10/30/2021

  • Register
    • Non-member - $40
    • Member - $30
    • Resident/Fellow - $10
    • Student - $10

    Continue

Completion of this activity will allow learners to identify first line antiretroviral therapies for the treatment of people living with HIV; discuss updates regarding the use of pre-exposure prophylaxis (PrEP); indicate that an HIV viral load that is "undetectable" via lab work, is equivalent to not transmitting HIV through sexual contact or IV drug use- this is known as Undetectable ='s Untransmittable (U=U); and discuss the clinical benefits of a same day start (rapid start) strategy.  This program was originally recorded on October 30, 2021 at the ACOI's 2021 Annual Convention and Scientific Sessions.

MarkAlain Dery, DO, FACOI

Chief Innovation Officer

Access Health Louisiana

Chief Innovation Officer
Medical Director of Infectious Diseases, Access Health Louisiana
Clinical Instructor of Medicine, Tulane University School of Medicine
New Orleans, Louisiana

Key:

Complete
Failed
Available
Locked
Acknowledgement
Agree to terms to continue.
Agree to terms to continue.
You must register to access.
Video
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin.
You must register to access.
Post-Test
5 Questions  |  Unlimited attempts  |  80/100 points to pass
5 Questions  |  Unlimited attempts  |  80/100 points to pass
You must register to access.
CME Certificate
Up to 0.75 medical credits available  |  Certificate available
Up to 0.75 medical credits available  |  Certificate available
You must register to access.